Kindly Md, INC

Nakamoto Inc. announced the resignation of Tim Pickett from his roles as director, Chief Medical Officer, and CEO of Kindly LLC, effective August 3, 2026, with a separation agreement in place.

Nakamoto Inc. announced significant capital structure initiatives including a $45 million debt reduction, refinancing of remaining debt with extended maturities, and a $25 million share repurchase program authorization, while also regaining Nasdaq compliance.

Nakamoto Inc. reports a net loss of $238.8 million for Q1 2026, driven by non-cash Bitcoin mark-to-market adjustments and acquisition costs.

Nakamoto Inc. announced the approval of two significant proposals by its stockholders at a special meeting held on May 8, 2026, including a reverse stock split.

Nakamoto Inc. has entered into new indemnification agreements with its directors and officers, strengthening their legal protections and expense advancements.

Nakamoto Inc. has finalized the all-stock acquisition of BTC Inc. and UTXO Management GP, LLC, consolidating major Bitcoin media, events, and fund management operations.

Nakamoto Inc. disclosed significant goodwill impairments totaling $105.2 million and a substantial net loss of $133.0 million for the quarter ended June 30, 2026, primarily driven by digital asset value declines and acquisition-related charges.

Nakamoto Inc. reports a significant net loss for Q1 2026 driven by Bitcoin price volatility and acquisition-related costs as it completes its transition to a Bitcoin-focused operating company.

KindlyMD reports a significant net loss and revenue decline in Q3 2025, driven by its strategic shift to Bitcoin treasury operations and the acquisition of Nakamoto Holdings.

KindlyMD announces a strategic merger with Nakamoto Holdings Inc. to adopt a Bitcoin treasury strategy, despite significant increases in net loss and operating expenses.

Kindly MD's Q1 2025 revenue decreased by 30.1% year-over-year, and the net loss increased significantly as the company transitions to insurance-based billing and invests in operational expansion.

Kindly MD's Q3 2024 results show a revenue decrease due to a shift towards insurance billing, alongside increased operating expenses, but the company's recent IPO has provided a significant boost to liquidity.

Kindly MD, Inc. files an amendment to its 2024 annual report to include a clawback policy for executive compensation in the event of financial restatements.

Kindly MD, Inc.'s annual report reveals a revenue decrease due to a strategic shift towards insurance-based billing, despite an increase in patient visits and ongoing efforts to combat the opioid epidemic.

Nakamoto Inc. CEO David F. Bailey acquired 55,115 shares of common stock in open market transactions.

CEO David Bailey acquired 136,333 shares of Nakamoto Inc. common stock through open market purchases between May 26 and May 27, 2026.

Nakamoto Inc.'s Chief Investment Officer, Tyler Matthew Evans, was granted 600,000 shares of common stock as part of his 2025 bonus payment.

Nakamoto Inc.'s Chief Investment Officer, Tyler Matthew Evans, filed an amended Form 4 to correct a scrivener's error regarding his beneficial ownership of common stock and derivative securities following recent mergers.

Nakamoto Inc.'s Chief Investment Officer, Tyler Matthew Evans, significantly increased his beneficial ownership of common stock and stock options following two merger agreements.

Nakamoto Inc. CEO David F. Bailey significantly increased his beneficial ownership of common stock following two merger agreements.

Nakamoto Inc. is seeking stockholder approval for a reverse stock split of its common stock at a ratio between 1-for-20 and 1-for-50 to regain Nasdaq listing compliance.

Kindly MD, Inc. announced its 2025 Annual Meeting of Shareholders to vote on director elections, a corporate reincorporation to Delaware, and auditor ratification.

Kindly MD, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on December 17, 2025, to vote on director elections, corporate reincorporation, auditor ratification, and meeting adjournment.

Kindly MD, Inc. is holding its 2025 Annual Meeting to vote on key proposals including the re-election of directors, a strategic conversion to a Delaware corporation, and the ratification of its independent auditor.

Kindly MD, Inc. is set to merge with Nakamoto Holdings Inc., fundamentally shifting its business focus from healthcare to a bitcoin treasury strategy, backed by over $763 million in new equity and debt financing.

KindlyMD is holding its annual stockholder meeting on November 8, 2024, to re-elect its five directors and ratify the selection of Sadler Gibb & Associates as its independent accounting firm.

Kindly MD details executive employment agreements, including compensation, responsibilities, and termination conditions, alongside corporate governance and legal considerations in a recent SEC filing.

Kindly MD formalizes Adam Cox's role as COO with a comprehensive employment agreement detailing compensation, responsibilities, and post-employment obligations.

Kindly MD, Inc. updates its S-1 registration statement, including audited financials for 2023, as it seeks an initial public offering and Nasdaq listing.

CEO David Bailey disclosed an 18.25% beneficial ownership stake in Nakamoto Inc. following recent open-market purchases.

David Bailey, Chairman and CEO of Nakamoto Inc., has disclosed a beneficial ownership of 17.33% of the company's common stock following a series of merger agreements.

Alyeska Investment Group, L.P. and Anand Parekh have filed a Schedule 13G reporting a 3.71% beneficial ownership stake in Nakamoto Inc. as of March 31, 2026.

Calli Sullivan Bailey reports a 15.96% beneficial ownership stake in Nakamoto Inc. through a Schedule 13G filing.

Gus Doodle LLC has filed an amended Schedule 13G, reporting a passive beneficial ownership of 4.15% of Kindly MD, Inc.'s common stock as of May 12, 2025.

Gus Doodle LLC has filed a Schedule 13G, reporting beneficial ownership of 4.98% of Kindly MD, Inc.'s common stock, indicating a passive investment.